在 COVID-19 大流行期间，为 SCA 患儿启动预防中风的辅助低剂量羟基脲治疗。

Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic.

出版信息

Blood. 2020 May 28;135(22):1997-1999. doi: 10.1182/blood.2020005992.

DOI:10.1182/blood.2020005992

PMID:32282033

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7256359/

Abstract

There is a Commentary on this article in this issue.

摘要

本期对这篇文章有评论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ded7/7256359/b4fb7b03e602/bloodBLD2020005992f1.jpg

相似文献

Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic.在 COVID-19 大流行期间，为 SCA 患儿启动预防中风的辅助低剂量羟基脲治疗。

Blood. 2020 May 28;135(22):1997-1999. doi: 10.1182/blood.2020005992.

Combination dose-escalated hydroxyurea and transfusion: an approach to conserve blood during the COVID-19 pandemic.联合递增剂量羟基脲与输血：一种在新冠疫情期间保存血液的方法。

Blood. 2020 Jun 18;135(25):2320-2322. doi: 10.1182/blood.2020006582.

Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial.接受羟基脲和放血或慢性输血和螯合治疗的镰状细胞贫血和既往卒中儿童的疼痛和其他非神经不良事件：SWiTCH 临床试验结果。

Am J Hematol. 2013 Nov;88(11):932-8. doi: 10.1002/ajh.23547. Epub 2013 Aug 30.

Expanding the role of hydroxyurea in children with sickle cell disease.扩大羟基脲在镰状细胞病患儿中的作用。

J Pediatr. 2004 Sep;145(3):287-8. doi: 10.1016/j.jpeds.2004.06.032.

Hydroxyurea as secondary prevention for stroke in children with sickle cell anemia.羟基脲作为镰状细胞贫血患儿中风的二级预防措施。

J Pediatr. 2005 Oct;147(4):560-1. doi: 10.1016/j.jpeds.2005.03.045.

Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload.羟基脲/放血疗法降低铁过载镰状细胞贫血儿童二次中风风险的长期结果。

Am J Hematol. 2011 Apr;86(4):357-61. doi: 10.1002/ajh.21986.

Approximately 40 000 children with sickle cell anemia require screening with TCD and treating with hydroxyurea for stroke prevention in three states in northern Nigeria.在尼日利亚北部的三个州，约4万名镰状细胞贫血患儿需要接受经颅多普勒超声（TCD）筛查，并使用羟基脲进行治疗以预防中风。

Am J Hematol. 2019 Nov;94(11):E305-E307. doi: 10.1002/ajh.25616. Epub 2019 Sep 11.

Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy.使用羟基脲和放血疗法预防镰状细胞贫血患儿的二次中风及解决输血性铁过载问题。

J Pediatr. 2004 Sep;145(3):346-52. doi: 10.1016/j.jpeds.2004.04.058.

Prospects for primary stroke prevention in children with sickle cell anaemia.镰状细胞贫血儿童一级卒中预防的前景。

Br J Haematol. 2012 Apr;157(1):14-25. doi: 10.1111/j.1365-2141.2011.09005.x. Epub 2012 Jan 9.

Stroke With Transfusions Changing to Hydroxyurea (SWiTCH).卒中患者输血转换为羟基脲治疗（SWiTCH）研究。

Blood. 2012 Apr 26;119(17):3925-32. doi: 10.1182/blood-2011-11-392340. Epub 2012 Feb 7.

引用本文的文献

Incidence and Risk Factors for New and Recurrent Infarcts in Adults With Sickle Cell Disease.镰状细胞病成人新发和复发性梗死的发生率及危险因素。

J Am Heart Assoc. 2024 Jun 18;13(12):e033278. doi: 10.1161/JAHA.123.033278. Epub 2024 Jun 6.

Covid-19 impacts: Ethnic and regional inequalities in sickle cell disease patient care in Brazil.新冠疫情的影响：巴西镰状细胞病患者护理中的种族和地区不平等现象

Heliyon. 2023 Nov 11;9(11):e21960. doi: 10.1016/j.heliyon.2023.e21960. eCollection 2023 Nov.

Provider prescription of hydroxyurea in youth and adults with sickle cell disease: A review of prescription barriers and facilitators.羟脲在青少年和成人镰状细胞病患者中的处方：处方障碍和促进因素的回顾。

Br J Haematol. 2023 Dec;203(5):712-721. doi: 10.1111/bjh.19099. Epub 2023 Sep 10.

Blood Transfusion Vs. Hydroxyurea for Stroke Prevention in Children With Sickle Cell Anemia: A Systematic Review and Meta-Analysis.输血与羟基脲预防镰状细胞贫血患儿中风的比较：系统评价与荟萃分析

Cureus. 2022 Nov 22;14(11):e31778. doi: 10.7759/cureus.31778. eCollection 2022 Nov.

Revisiting anemia in sickle cell disease and finding the balance with therapeutic approaches.重新审视镰状细胞病中的贫血症，并找到治疗方法的平衡点。

Blood. 2022 May 19;139(20):3030-3039. doi: 10.1182/blood.2021013873.

Pathogenic Basis of Thromboinflammation and Endothelial Injury in COVID-19: Current Findings and Therapeutic Implications.新型冠状病毒肺炎血栓炎症与血管内皮损伤的发病基础：目前的研究结果与治疗意义

Int J Mol Sci. 2021 Nov 8;22(21):12081. doi: 10.3390/ijms222112081.

Philadelphia-Negative Chronic Myeloproliferative Neoplasms during the COVID-19 Pandemic: Challenges and Future Scenarios.新冠疫情期间的费城染色体阴性慢性骨髓增殖性肿瘤：挑战与未来展望

Cancers (Basel). 2021 Sep 23;13(19):4750. doi: 10.3390/cancers13194750.

Psoriasis Management During the COVID-19 Pandemic: Recommendations by SIG Psoriasis (IADVL Academy).2019冠状病毒病大流行期间的银屑病管理：银屑病特别兴趣小组（印度皮肤科、性病与麻风病学协会学会）的建议

Indian Dermatol Online J. 2021 Jan 16;12(1):58-65. doi: 10.4103/idoj.IDOJ_685_20. eCollection 2021 Jan-Feb.

A comprehensive review of hydroxyurea for β-haemoglobinopathies: the role revisited during COVID-19 pandemic.羟脲在β-地中海贫血症中的应用综述：COVID-19 大流行期间的作用再探讨。

Orphanet J Rare Dis. 2021 Mar 1;16(1):114. doi: 10.1186/s13023-021-01757-w.

COVID-19 pandemic and transfusion medicine: the worldwide challenge and its implications.COVID-19 大流行与输血医学：全球性挑战及其影响。

Ann Hematol. 2021 May;100(5):1115-1122. doi: 10.1007/s00277-021-04441-y. Epub 2021 Feb 1.

本文引用的文献

"Maximum tolerated dose" vs "fixed low-dose" hydroxyurea for treatment of adults with sickle cell anemia.“最大耐受剂量”与“固定低剂量”羟基脲治疗成人镰状细胞贫血的比较

Am J Hematol. 2019 Apr;94(4):E112-E115. doi: 10.1002/ajh.25412. Epub 2019 Feb 6.

Beneficial Effect of Low Fixed Dose of Hydroxyurea in Vaso-occlusive Crisis and Transfusion Requirements in Adult HbSS Patients: A Prospective Study in a Tertiary Care Center.低固定剂量羟基脲对成年HbSS患者血管闭塞性危象和输血需求的有益影响：在三级医疗中心的一项前瞻性研究

Indian J Hematol Blood Transfus. 2018 Apr;34(2):294-298. doi: 10.1007/s12288-017-0869-x. Epub 2017 Sep 4.

Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial).尼日利亚镰状细胞贫血患儿原发性卒中预防可行性试验（SPIN试验）。

Am J Hematol. 2018 Mar;93(3):E83. doi: 10.1002/ajh.25012. Epub 2018 Feb 2.

Secondary benefit of maintaining normal transcranial Doppler velocities when using hydroxyurea for prevention of severe sickle cell anemia.使用羟基脲预防重度镰状细胞贫血时维持正常经颅多普勒速度的次要益处。

Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26401. Epub 2016 Dec 30.

Central nervous system complications and management in sickle cell disease.镰状细胞病的中枢神经系统并发症及处理。

Blood. 2016 Feb 18;127(7):829-38. doi: 10.1182/blood-2015-09-618579. Epub 2016 Jan 12.

Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.羟基脲与慢性输血用于维持镰状细胞贫血患儿经颅多普勒血流速度的比较——输血转换为羟基脲的经颅多普勒研究（TWiTCH）：一项多中心、开放标签、3期、非劣效性试验。

Lancet. 2016 Feb 13;387(10019):661-670. doi: 10.1016/S0140-6736(15)01041-7. Epub 2015 Dec 6.

How I treat and manage strokes in sickle cell disease.我如何治疗和管理镰状细胞病中的中风。

Blood. 2015 May 28;125(22):3401-10. doi: 10.1182/blood-2014-09-551564. Epub 2015 Mar 30.

Stroke recurrence in Nigerian children with sickle cell disease treated with hydroxyurea.接受羟基脲治疗的尼日利亚镰状细胞病患儿的中风复发情况。

Niger Postgrad Med J. 2013 Sep;20(3):181-7.

Stroke recurrence in children with sickle cell disease treated with hydroxyurea following first clinical stroke.儿童镰状细胞病首次临床卒中后用羟基脲治疗后的卒中复发。

Am J Hematol. 2011 Oct;86(10):846-50. doi: 10.1002/ajh.22142. Epub 2011 Sep 2.

Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.对镰状细胞贫血且经颅多普勒超声检查结果异常的儿童进行输血以预防首次中风

N Engl J Med. 1998 Jul 2;339(1):5-11. doi: 10.1056/NEJM199807023390102.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

在 COVID-19 大流行期间，为 SCA 患儿启动预防中风的辅助低剂量羟基脲治疗。

Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic.

出版信息

相似文献

引用本文的文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献